IRulya Therapeutics (IRLA) Other Non Operating Income (2021 - 2026)
IRulya Therapeutics (IRLA) reported Other Non Operating Income of -$3.05 million for Q2 2026, compared with $4.44 million a year earlier.
Powered by 
Analysis
IRulya Therapeutics (IRLA) Other Non Operating Income (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, IRulya Therapeutics' Other Non Operating Income came in at -$10.35 million; for FY2025, it was $21.99 million.
- By year, Other Non Operating Income came in at -$676,000 in FY2024, -$102,000 in FY2023, -$997,000 in FY2022 and -$247,000 in FY2021.
- Five-year quarterly Other Non Operating Income spans a low of -$29.4 million in Q1 2026 and a high of $22.16 million in Q4 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$29.4 million (Q1 2026), $22.16 million (Q4 2025) and -$58,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.05 Mn |
| Mar 31, 2026 | -29.40 Mn |
| Dec 31, 2025 | 22.16 Mn |
| Sep 30, 2025 | -58,000.00 |
| Jun 30, 2025 | 4.44 Mn |
| Mar 31, 2025 | -87,000.00 |
| Dec 31, 2024 | -518,000.00 |
| Sep 30, 2024 | 150,000.00 |
| Jun 30, 2024 | 91,000.00 |
| Mar 31, 2024 | -399,000.00 |
| Dec 31, 2023 | 402,000.00 |
| Sep 30, 2023 | -216,000.00 |
| Jun 30, 2023 | -107,000.00 |
| Mar 31, 2023 | -246,000.00 |
| Dec 31, 2022 | 249,000.00 |
| Sep 30, 2022 | -616,000.00 |
| Jun 30, 2022 | -735,000.00 |
| Mar 31, 2022 | 150,000.00 |
| Dec 31, 2021 | 40,000.00 |
| Sep 30, 2021 | -157,000.00 |
API Access
IRulya Therapeutics Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();